Efficacy, safety, and tolerability of imepitoin in dogs with newly diagnosed epilepsy in a randomized controlled clinical study with long-term follow up

BACKGROUND: Imepitoin is a novel antiepileptic drug for the treatment of canine idiopathic epilepsy. The present study was conducted to demonstrate superior antiepileptic activity of a high dose of 30 mg/kg BID over a low dose of 1 mg/kg BID of imepitoin during 12 weeks of treatment under double bli...

Descripción completa

Detalles Bibliográficos
Autores principales: Rundfeldt, Chris, Tipold, Andrea, Löscher, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556053/
https://www.ncbi.nlm.nih.gov/pubmed/26330063
http://dx.doi.org/10.1186/s12917-015-0548-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556053/
https://www.ncbi.nlm.nih.gov/pubmed/26330063
http://dx.doi.org/10.1186/s12917-015-0548-9

Ejemplares similares